Clinical Programs - Confidence through Evidence - Concept Medical
Clinical Programs
Abluminus DES+
Sr. No Study Name Target Patients Country Clinical Trials Identifier Sponsor No of Centers Enrollment Status Indication Design Publication
Sr. No:  1 Study Name:   ABILITY DIABETES GLOBAL Target Patients:  3050 Country:  South America, Asia, Europe and Russia Clinical Trials Identifier:   NCT04236609 Sponsor:  Concept Medical No of Centers:  100 Enrollment Status:  Completed Indication:  DM Design:  Abluminus V/S Xience Family Publication:  
Sr. No:  2 Study Name:   Ability RCT Target Patients:  150 Country:  Italy Clinical Trials Identifier:   NCT03399994 Sponsor:  IIT No of Centers:  6 Enrollment Status:  Completed Indication:  DM Design:  Abluminus V/S EES Publication:  
Sr. No:  3 Study Name:   en-ABL 1 Study Target Patients:  40 Country:  India Clinical Trials Identifier:   Sponsor:  Concept Medical No of Centers:  1 Enrollment Status:  Completed Indication:  CAD Design:  Single Arm Publication:  
Sr. No:  4 Study Name:   Dedicate Registry Target Patients:  3,000 Country:  EU And Asia Clinical Trials Identifier:   NCT03509532 Sponsor:  IIT No of Centers:  34 Enrollment Status:  Ongoing Indication:  DM Design:  Single Arm Publication:  
Sr. No:  5 Study Name:   en-ABL e-REGISTRY Target Patients:  2,500 Country:  India Clinical Trials Identifier:   - Sponsor:  Concept Medical No of Centers:  31 Enrollment Status:  Completed Indication:  CAD Design:  Single Arm Publication:   View
Sr. No:  6 Study Name:   CUT-DRESS RCT Target Patients:  96 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
Sr. No:  7 Study Name:   CUT-DRESS Registry Target Patients:  608 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
MagicTouch SCB
Sr. No Study Name Target Patients Country Clinical Trials Identifier Sponsor No of Centers Enrollment Status Indication Design Publication
Sr. No:  1 Study Name:   EASTBOURNE Target Patients:  2123 Country:  India, Malaysia, Greece, Italy, Spain, Ireland Clinical Trials Identifier:   NCT03085823 Sponsor:  IIT No of Centers:  51 Enrollment Status:  Completed Indication:  Native Vessel and ISR Design:  Single Arm Publication:   View
Sr. No:  2 Study Name:   Nanolute Target Patients:  450 Country:  India Clinical Trials Identifier:   Sponsor:  Concept Medical No of Centers:  63 Enrollment Status:  Completed Indication:   De-novo, ISR, small vessels, bifurcation lesions Design:  Single Arm Publication:   View
Sr. No:  3 Study Name:   Transform I Target Patients:  114 Country:  Italy, UK, Ireland Clinical Trials Identifier:   NCT03913832 Sponsor:  Concept Medical No of Centers:  7 Enrollment Status:  Completed Indication:  De-novo lesion in small vessels Design:  RCT Publication:   View
Sr. No:  4 Study Name:   Brazil-FIM Target Patients:  30 Country:  Brazil Clinical Trials Identifier:   NCT02400632 Sponsor:  Concept Medical No of Centers:  1 Enrollment Status:  Completed Indication:  Intra-stent restenosis Design:  Single Arm Publication:  
Sr. No:  5 Study Name:   FASICO Target Patients:  32 Country:  Italy Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  1 Enrollment Status:  Completed Indication:  Native Vessel and ISR Design:  Single Arm Publication:  
Sr. No:  6 Study Name:   UK-SEB REGISTRY Target Patients:  500 Country:  UK Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  2 Enrollment Status:  Completed Indication:  De novo lesions & ISR Design:  Single Arm Publication:   View
Sr. No:  7 Study Name:   Nanolute CIMS Target Patients:  131 Country:  India Clinical Trials Identifier:   Sponsor:  IIT No of Centers:  1 Enrollment Status:  Completed Indication:   De-novo, ISR, small vessels, bifurcation lesions Design:  Single Arm Publication:  
Sr. No:  8 Study Name:   SELFIE Target Patients:  62 Country:  Italy Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  1 Enrollment Status:  Completed Indication:  ACS Design:  Single Arm Publication:   View
Sr. No:  9 Study Name:   JAPAN - ISR Target Patients:  50 Country:  Japan Clinical Trials Identifier:   - Sponsor:  - No of Centers:  20 Enrollment Status:  Completed Indication:  ISR Design:  Single Arm Publication:  
Sr. No:  10 Study Name:   Japan – SV Target Patients:  170 Country:  Japan Clinical Trials Identifier:   - Sponsor:  - No of Centers:  20 Enrollment Status:  Completed Indication:  Small vessels Design:  RCT Publication:  
Sr. No:  11 Study Name:   UK-SEB REGISTRY 2 Target Patients:  1000 Country:  UK Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  10 Enrollment Status:  Ongoing Indication:  De novo lesions & ISR Design:  Single Arm Publication:  
Sr. No:  12 Study Name:   TRANFORM II Target Patients:  1325 Country:  Italy, UK, Poland, Spain, Portugal, The Netherlands Clinical Trials Identifier:   NCT04893291 Sponsor:  IIT No of Centers:  28 Enrollment Status:  Ongoing Indication:  Small vessels Design:  RCT Publication:  
Sr. No:  13 Study Name:   PICCOLETO III (RCT) Target Patients:  450 Country:  Italy, UK Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  - Enrollment Status:  Planned Indication:  - Design:  RCT Publication:  
Sr. No:  14 Study Name:   GINGER Target Patients:  100 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
Sr. No:  15 Study Name:   TITAN Target Patients:  130 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
Sr. No:  16 Study Name:   The MAGICAL Registry (US FDA) Target Patients:  300 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
Sr. No:  17 Study Name:   The MAGICAL RCT (US FDA) Target Patients:  120 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
Sr. No:  18 Study Name:   Hybrid Bifurcation PCI Target Patients:  500 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
MagicTouch AVF
Sr. No Study Name Target Patients Country Clinical Trials Identifier Sponsor No of Centers Enrollment Status Indication Design Publication
Sr. No:  1 Study Name:   MAGICTOUCH AVF IN SALVAGE OF AVG Target Patients:  20 Country:  Singapore Clinical Trials Identifier:   NCT03666208 Sponsor:  IIT No of Centers:  1 Enrollment Status:  Completed Indication:  Thrombosed AVG Design:  Single Arm Publication:   View
Sr. No:  2 Study Name:   MATILDA Target Patients:  33 Country:  Singapore Clinical Trials Identifier:   NCT04698512 Sponsor:  IIT No of Centers:  1 Enrollment Status:  Completed Indication:  Thrombosed AVF Design:  Single Arm Publication:   View
Sr. No:  3 Study Name:   IMPRESSION Target Patients:  170 Country:  Singapore Clinical Trials Identifier:   NCT04409912 Sponsor:  Concept Medical No of Centers:  3 Enrollment Status:  Ongoing Indication:  Dysfunctional AVF Design:  RCT Publication:   View
Sr. No:  4 Study Name:   Magic Touch AVF – US FDA Target Patients:  376 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication:  
MagicTouch ED
Sr. No Study Name Target Patients Country Clinical Trials Identifier Sponsor No of Centers Enrollment Status Indication Design Publication
Sr. No:  1 Study Name:   Suasion Registry Target Patients:  100 Country:  Italy Clinical Trials Identifier:   NCT04345965 Sponsor:  IIT No of Centers:  3 Enrollment Status:  Ongoing Indication:  ED Design:  Single Arm Publication:  
Sr. No:  2 Study Name:   LIBIDO RCT Target Patients:  64 Country:  Italy, Switzerland, Germany, Grecia, Lithuania Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  5 Enrollment Status:  Planned Indication:  ED Design:  RCT Publication:  
MagicTouch PTA
Sr. No Study Name Target Patients Country Clinical Trials Identifier Sponsor No of Centers Enrollment Status Indication Design Publication
Sr. No:  1 Study Name:   X-TOSI Target Patients:  50 Country:  Singapore Clinical Trials Identifier:   NCT04368091 Sponsor:  Concept Medical No of Centers:  1 Enrollment Status:  Completed Indication:  Infrainguinal PAD Design:  Single Arm Publication:  
Sr. No:  2 Study Name:   XTREME FIM Target Patients:  39 Country:  India Clinical Trials Identifier:   - Sponsor:  Concept Medical No of Centers:  1 Enrollment Status:  Completed Indication:  PAD Design:  Single Arm Publication:  
Sr. No:  3 Study Name:   FUTURE BTK ASIA Target Patients:  219 Country:  Singapore, Taiwan, Thailand, Korea Clinical Trials Identifier:   NCT04511247 Sponsor:  Concept Medical No of Centers:  25 Enrollment Status:  Ongoing Indication:  BTK Design:  RCT Publication:  
Sr. No:  4 Study Name:   LIMES Target Patients:  250 Country:  Germany & Austria Clinical Trials Identifier:   NCT04772300 Sponsor:  IIT No of Centers:  31 Enrollment Status:  Ongoing Indication:  BTK Design:  RCT Publication:  
Sr. No:  5 Study Name:   FUTURE SFA ASIA Target Patients:  279 Country:  Singapore, Taiwan, Thailand, Korea Clinical Trials Identifier:   NCT04511234 Sponsor:  Concept Medical No of Centers:  25 Enrollment Status:  Ongoing Indication:  SFA & Popliteal Artery Disease Design:  RCT Publication:  
Sr. No:  6 Study Name:   SIRONA Target Patients:  478 Country:  Germany & Austria Clinical Trials Identifier:   NCT04475783 Sponsor:  IIT No of Centers:  1 Enrollment Status:  Ongoing Indication:  PAD Design:  RCT Publication:   View
Sr. No:  7 Study Name:   The DEBATE BTK DUELL Target Patients:  172 Country:  Italy Clinical Trials Identifier:   NCT04594889 Sponsor:  IIT No of Centers:  6 Enrollment Status:  Ongoing Indication:  BTK - CLI Design:  RCT Publication:  
Sr. No:  8 Study Name:   MATSA-Spain Target Patients:  150 Country:  Spain Clinical Trials Identifier:   - Sponsor:  IIT No of Centers:  5 Enrollment Status:  Planned Indication:  femoropopliteal occlusive arterial disease Design:  Single Arm Publication:  
Sr. No:  9 Study Name:   SirPAD Target Patients:  1132 Country:  Switzerland Clinical Trials Identifier:   NCT04238546 Sponsor:  IIT No of Centers:  1 Enrollment Status:  Ongoing Indication:  SFA & BTK Design:  RCT Publication:  
Abluminus NP
Sr. No Study Name Target Patients Country Clinical Trials Identifier Sponsor No of Centers Enrollment Status Indication Design Publication
Sr. No:  1 Study Name:   Nanolute PMS Target Patients:  450 Country:  India Clinical Trials Identifier:   - Sponsor:  Concept Medical No of Centers:  63 Enrollment Status:  Completed Indication:  Observational - Prospective - Registry Design:  - Publication:  
Sr. No:  2 Study Name:   NANOACTIVE FIM Target Patients:  86 Country:  India Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:   Indication:   Design:   Publication:  
Sr. No:  3 Study Name:   STARS DAPT Target Patients:  348 Country:   Clinical Trials Identifier:   Sponsor:   No of Centers:   Enrollment Status:  Planned Indication:   Design:   Publication: